MapLight Therapeutics
(NASDAQ) MPLT
MapLight Therapeutics Financials at a Glance
Market Cap
$898.38M
Revenue (TTM)
$0.00
Net Income (TTM)
$161.15M
EPS (TTM)
$-3.71
P/E Ratio
-5.70
Dividend
$0.00
Beta (Volatility)
2.10 (High)
Dividend
$0.00
Beta (Volatility)
2.10 (High)
Price
$21.23
Volume
146,587
Open
$20.58
Price
$21.23
Volume
146,587
Open
$20.58
Previous Close
$21.17
Daily Range
$20.31 - $21.76
52-Week Range
$12.24 - $21.76
Dividend
$0.00
Beta (Volatility)
2.10 (High)
Price
$21.23
Volume
146,587
Open
$20.58
Previous Close
$21.17
Daily Range
$20.31 - $21.76
52-Week Range
$12.24 - $21.76
MPLT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MapLight Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
133
CEO
Christopher A. Kroeger, MD, MBA
Website
www.maplightrx.comHeadquarters
Redwood City, CA 94063, US
MPLT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-36%
Return on Assets
-34%
Earnings Yield
-17.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$898.38M
Shares Outstanding
42.44M
Volume
146.59K
Short Interest
0.00%
Avg. Volume
197.24K
Financials (TTM)
Gross Profit
$578.00K
Operating Income
$169.08M
EBITDA
$168.50M
Operating Cash Flow
$138.14M
Capital Expenditure
$473.00K
Free Cash Flow
$138.61M
Cash & ST Invst.
$305.10M
Total Debt
$5.80M
MapLight Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$140.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$898.38M
N/A
Market Cap/Employee
$8.24M
N/A
Employees
109
N/A
Net Income
$79.55M
-274.7%
EBITDA
$83.24M
-268.6%
Quarterly Fundamentals
Net Cash
$299.30M
+192.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$4.91M
-15.3%
Short Term Debt
$891.00K
-42.7%
Return on Assets
-33.61%
N/A
Return on Invested Capital
-36.50%
N/A
Free Cash Flow
$47.20M
-118.6%
Operating Cash Flow
$46.83M
-117.9%